These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21551089)

  • 41. Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary care.
    Borrelli S; Chiodini P; De Nicola L; Minutolo R; Provenzano M; Garofalo C; Remuzzi G; Ronco C; Cozzolino MG; Manno C; Costanzo AM; Gualberti G; Conte G
    PLoS One; 2018; 13(8):e0202417. PubMed ID: 30138402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Focused clinical campaign improves mineral and bone disorder outcomes.
    Benner D; Nissenson AR; Van Wyck D
    J Ren Care; 2012 Mar; 38(1):2-8. PubMed ID: 22369592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Refining the definition of clinically important mineral and bone disorder in hemodialysis patients.
    Danese MD; Halperin M; Lowe KA; Bradbury BD; Do TP; Block GA
    Nephrol Dial Transplant; 2015 Aug; 30(8):1336-44. PubMed ID: 25817224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic kidney disease: Levels of phosphorus and patient outcomes.
    Foley RN
    Nat Rev Nephrol; 2011 Jun; 7(8):428-30. PubMed ID: 21712850
    [No Abstract]   [Full Text] [Related]  

  • 45. [Chronic kidney disease (CKD) and bone. Impact of diabetes mellitus on the development of CKD-MBD].
    Inaba M
    Clin Calcium; 2009 Apr; 19(4):502-7. PubMed ID: 19329828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dysregulation of the calcium, phosphorus, parathyroid hormone, and vitamin D axis: what are the causes and risks?
    Bushinsky DA
    Am J Kidney Dis; 2001 Jun; 37(6):1310-2. PubMed ID: 11382706
    [No Abstract]   [Full Text] [Related]  

  • 47. Does dietary therapy have a role in the predialysis patient?
    Walser M
    Am J Clin Nutr; 1980 Jul; 33(7):1629-37. PubMed ID: 7395783
    [No Abstract]   [Full Text] [Related]  

  • 48. Consistent control of mineral and bone disorder in incident hemodialysis patients.
    Danese MD; Belozeroff V; Smirnakis K; Rothman KJ
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1423-9. PubMed ID: 18596117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parathormone activity and rate of progression of chronic renal failure in patients on low-protein diet.
    Aparicio M; Gin H; Merville P; Combe C; de Precigout V; Lafage MH; Bouchet JL; Potaux L
    Nephron; 1990; 56(3):333-4. PubMed ID: 2077420
    [No Abstract]   [Full Text] [Related]  

  • 50. Changes in serum calcium and phosphorus induced by chronic renal failure in the absence of parathyroid hormone.
    Rodriguez M; Lorenzo V; Felsenfeld AJ; Llach F
    Adv Exp Med Biol; 1986; 208():383-6. PubMed ID: 3565155
    [No Abstract]   [Full Text] [Related]  

  • 51. Improving clinical processes: one dialysis facility's experiences.
    Bennett J; Cranford W; Staples B; Hartline P; Blondin J; Harter H; Rutherford WE
    Qual Manag Health Care; 1997; 6(1):45-60. PubMed ID: 10176408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FGF-23 and outcomes research--when physiology meets epidemiology.
    Hsu CY
    N Engl J Med; 2008 Aug; 359(6):640-2. PubMed ID: 18687647
    [No Abstract]   [Full Text] [Related]  

  • 53. Estrogen deficiency - does it play a role in uremic bone disease?
    Cengiz K
    Nephron; 1997; 77(3):363-4. PubMed ID: 9375837
    [No Abstract]   [Full Text] [Related]  

  • 54. Impact of oral calcium on mortality of dialysis patients--an underestimated risk?
    Bommer J; Ketteler M; Ritz E
    Nephrol Dial Transplant; 2012 Jul; 27(7):2628-33. PubMed ID: 22535633
    [No Abstract]   [Full Text] [Related]  

  • 55. Calcium and phosphorus control.
    Lindsay RM; Pierratos A; Lockridge RS
    Contrib Nephrol; 2004; 145():63-68. PubMed ID: 15496792
    [No Abstract]   [Full Text] [Related]  

  • 56. Re-evaluating our approach to calcium and phosphorus management in dialysis patients.
    Keith DS
    Am J Kidney Dis; 2001 Jun; 37(6):1331-3. PubMed ID: 11382711
    [No Abstract]   [Full Text] [Related]  

  • 57. Causes of lability in PTH values.
    Indridason OS
    Semin Dial; 2000; 13(5):337. PubMed ID: 11014700
    [No Abstract]   [Full Text] [Related]  

  • 58. [Study of phosphorus and calcium metabolism in chronic renal insufficiency].
    Ulmann A
    Rev Prat; 1980 Sep; 30(39):2547-50. PubMed ID: 7433850
    [No Abstract]   [Full Text] [Related]  

  • 59. Mineral content of iliac crest bone in patients with chronic renal failure.
    Kaye M
    Clin Nephrol; 1973; 1(6):347-50. PubMed ID: 4786574
    [No Abstract]   [Full Text] [Related]  

  • 60. Bone loss in the early period after renal transplantation.
    Hakemi M; Ganji MR; Najafi I
    Transplant Proc; 2003 Nov; 35(7):2724. PubMed ID: 14612092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.